| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.04 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |